These results indicate that DMT1 silencing in triple-negative breast cancer cells induces a novel iron phenotype, that is characterized by decreased EE-mitochondria interactions, increased LIP levels, and promotes lung metastatic outgrowth (Fig. 6D). The gene discussed is SLC11A2; the disease is triple-negative breast carcinoma.